Multicentric Registry of Patients With Acute Leukemia Infected by COVID-19
NCT ID: NCT04452604
Last Updated: 2022-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
79 participants
OBSERVATIONAL
2020-09-11
2021-07-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main objective of the study is to determine the clinical and biological prognostic factors during SARS-CoV-2 infection in patients with acute leukemia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia
NCT01819792
Observatory of Patients With Chronic Lymphocytic Leukemia / Lymphocytic Lymphoma or Waldenstrom Disease Infected With COVID-19
NCT04391946
COVID-19 Epidemic and Patients With Myeloproliferative Neoplasias
NCT04416438
Efficiency of Antibacterial Prophylaxis in Azacitidine Treated Patients
NCT03594149
Chronic Myeloid Leukemia (CML) Real-Life Database
NCT05963061
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of a proven or probable SARS-CoV-2 infection according to the following criteria:
1. Proven infection: positive Polymerase Chain Reaction (PCR) regardless of the radio-clinical picture (other tests made available later and having good diagnostic performance will be accepted)
2. Probable infection: negative PCR but association of
1. Evocative clinical signs, of recent installation: fever, respiratory signs (cough, dyspnea, chest pain), body aches, sore throat, rhinorrhea, headache, diarrhea / abdominal pain, frank asthenia, loss of taste / smell, conjunctivitis, type of frostbite AND
2. evocative radiological signs, on CT: diffuse or diffuse aspect of frosted glass, condensations including pseudo-nodular condensations, association of frosted glass and condensation within the same lesion, nodules and micronodules, thickening of the interlobular septa) or on chest radiography: interstitial, alveolo-interstitial or alveolar syndrome, single or bilateral AND
3. absence of differential diagnosis
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Acute Leukemia French Association
OTHER
Group for Research in Adult Acute Lymphoblastic Leukemia
OTHER
French Innovative Leukemia Organisation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pierre-Yves DUMAS, Dr
Role: PRINCIPAL_INVESTIGATOR
French Innovative Leukemia Organisation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Amiens
Amiens, , France
CHU ANGERS - Maladies du sang
Angers, , France
Ch Avignon
Avignon, , France
CH de la Côte Basque - Hématologie
Bayonne, , France
CHU Caen - IHBN - Hématologie Clinique
Caen, , France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, , France
Centre Hospitalier de Dunkerque
Dunkirk, , France
CHU de Grenoble - Hopital Michallon
Grenoble, , France
Centre Hospitalier du Mans
Le Mans, , France
Hôpital Saint Vicent de Paul
Lille, , France
Chu Limoges
Limoges, , France
Institut Paoli-Calmettes - Hématologie 2
Marseille, , France
HOPITAL SAINT ELOI - Hematologie
Montpellier, , France
HOPITAL E. MULLER - Hématologie
Mulhouse, , France
CHU HOTEL DIEU - Hématologie Clinique
Nantes, , France
CHU Caremeau
Nîmes, , France
CENTRE HOSPITALIER SAINTJEAN - Hématologie Clinique
Perpignan, , France
Bordeaux Pessac
Pessac, , France
Centre Hospitalier Lyon Sud
Pierre-Bénite, , France
CHU Reims - Hôpital Robert Debré - Hématologie Clinique
Reims, , France
CHU Pontchaillou - Hématologie
Rennes, , France
Chu de La Reunion - Site Sud
Saint-Pierre, , France
Institut de Cancérologie Lucien Neuwirth
Saint-Priest-en-Jarez, , France
Institut Universitaire du Cancer de Toulouse Oncopole - Service d'Hématologie
Toulouse, , France
CHU de Brabois
Vandœuvre-lès-Nancy, , France
Centre Hospitalier de Versailles
Versailles, , France
Institut Gustave Roussy
Villejuif, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COVLA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.